跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
福瑞达 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Loteprednol Etabonate and Tobramycin Eye Drops
Approved
化学药品
Loteprednol Etabonate and Tobramycin Eye Drops
Bausch & Lomb Incorporated
🇨🇳 National Medical Products Administration
Approval Date
Jun 19, 2020
Approval ID
7MazXc1DvxP
Company
Bausch & Lomb Incorporated
Type
化学药品
Approval Details
Approval Id
7MazXc1DvxP
Approval Number
H20160349
Generic Name
氯替泼诺妥布霉素滴眼液
Generic Name En
Loteprednol Etabonate and Tobramycin Eye Drops
Brand Name
福瑞达
Drug Type
化学药品
Dosage Form
眼用制剂
Strength
5ml:氯替泼诺25mg与妥布霉素15mg
Reg Date
2020-06-19
Expired Date
2025-06-18
Company Name
Bausch & Lomb Incorporated
Company Address
400 Somerset Corporate Blvd, Bridgewater, NJ 08807 USA
Production Company Name
Bausch & Lomb Incorporated
Production Company Address
8500 Hidden River Parkway, Tampa, Florida 33637,USA
Company Detail Path
/organization/bausch-and-lomb-incorporated
Production Company Detail Path
/organization/bausch-and-lomb-incorporated
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jun 19, 2020
Approval ID
7MazXc1DvxP
Type
化学药品
Back to NMPA Approvals